Alkermes to sell its Gainesville manufacturing plant
Alkermes PLC on Monday announces that it has entered into a definitive agreement to sell its manufacturing facility in Gainesville, Ga., the manufacturing and royalty revenue associated with products manufactured at the facility and global rights to Meloxicam IV/IM to Recro Pharma, Inc., a specialty pharmaceutical company. Read More »